Alibaba Health Information Technology Ltd. announced the grant of share options and restricted share units under its 2024 Share Award Scheme. On June 13, 2025, the company issued a total of 1,701,000 share options to one connected grantee, who is a director, and 44,682,300 restricted share units to 594 grantees. This move is in accordance with the terms of the scheme adopted at the annual general meeting on August 30, 2024, and is subject to grantee acceptance. These new compensation terms are aimed at aligning the interests of the grantees with those of the shareholders.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.